ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07885
0,00%
Bitcoin
60.813,86
0,03%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. BioPharmX Corporation (BPMX)

  7. BioPharmX Corporation (BPMX) News

BPMX

BioPharmX (BPMX)

BioPharmX Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:BPMX
DatumZeitQuelleÜberschriftSymbolFirma
29/05/202012h04Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
28/05/202023h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
27/05/202023h23Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
22/05/202023h17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
19/05/202022h41GlobeNewswire Inc.Timber Pharmaceuticals Announces Investor Conference CallAMEX:BPMXBioPharmX Corporation
15/05/202022h36Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
15/05/202022h05PR Newswire (US)BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020AMEX:BPMXBioPharmX Corporation
13/05/202022h33Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
13/05/202022h31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
13/05/202022h05PR Newswire (US)BioPharmX Corporation Announces Approval of Merger by Stockholders at Special MeetingAMEX:BPMXBioPharmX Corporation
11/05/202022h09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
11/05/202022h09Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
08/05/202015h00PR Newswire (US)BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber PharmaceuticalsAMEX:BPMXBioPharmX Corporation
07/05/202012h05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
27/04/202022h20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BPMXBioPharmX Corporation
27/04/202022h13Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
27/04/202022h12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
27/04/202022h05PR Newswire (US)BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 A...AMEX:BPMXBioPharmX Corporation
06/04/202022h55Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
06/04/202022h53Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
06/04/202022h30PR Newswire (US)Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials GrantAMEX:BPMXBioPharmX Corporation
01/04/202022h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
01/04/202012h01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
30/03/202022h04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
30/03/202022h02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
30/03/202012h17Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:BPMXBioPharmX Corporation
25/03/202021h15PR Newswire (US)BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain TradingAMEX:BPMXBioPharmX Corporation
23/03/202021h24Edgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
20/02/202012h03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:BPMXBioPharmX Corporation
18/02/202022h04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
 Showing the most relevant articles for your search:AMEX:BPMX

Kürzlich von Ihnen besucht

TG
RHM
Rheinmetall
USOTC
RHHBY
Roche (QX)
FX
EURGBP
Euro vs Sterling
USOTC
BASFY
BASF (QX)
NYSE
JPM
JP Morgan Chase
USOTC
BNPQY
BNP Paribas (QX)
TG
432
Arbor Metals
TG
TUI1
Tui
NYSE
XOM
Exxon Mobil
DBI
MDAX
MDAX
DBI
TDXP
Tec DAX
TG
DBK
Deutsche Bank
TG
CBK
Commerzbank
NASDAQ
NVDA
NVIDIA
TG
MBG
MercedesBenz
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten